Partnering with mid-sized pharma
Partnering with mid-sized pharma
| Altana | ||
| ALT is developing therapeutics in oncology and for respiratory and gastrointestinal disorders. ALT's pharma group has 7,504 employees. The group reported 2002 R&D expenses of E335 million ($351 million), which represented 18% of pharma sales. | ||
| Pharma deals | Date | Deal type |
| Aventis | 4/01 | Develop and market ALT respiratory compound in U.S. |
| Pharmacia | ||
